Search for: "E. R. Squibb "
Results 41 - 60
of 71
Sort by Relevance
|
Sort by Date
18 Apr 2012, 4:40 pm
., R. [read post]
15 Feb 2012, 7:42 am
Peter Rost e-mailDr. [read post]
14 Sep 2011, 12:08 pm
Peter Rost e-mailDr. [read post]
14 Sep 2011, 12:08 pm
Peter Rost e-mailDr. [read post]
14 Sep 2011, 12:07 pm
Peter Rost e-mailDr. [read post]
14 Sep 2011, 12:07 pm
Peter Rost e-mailDr. [read post]
9 Sep 2011, 8:40 am
Peter Rost e-mailDr. [read post]
25 Aug 2011, 7:01 am
R. [read post]
22 Jun 2011, 7:09 am
Peter Rost e-mailDr. [read post]
28 Apr 2011, 3:18 pm
Thus “[w]e do not believe comment k was intended to provide nor should it provide all ethical drugs with blanket immunity from strict liability design defect claims. [read post]
15 Apr 2011, 6:02 am
Bristol-Myers Squibb, 1998 WL 812318, at *46 (M.D. [read post]
11 Feb 2011, 7:51 am
Peter Rost e-mailDr. [read post]
17 Nov 2010, 1:48 am
(FDA Law Blog) Crestor (Rosuvastatin) – US: AstraZeneca defeats Teva’s claim that Crestor infringes Teva’s patent (Orange Book Blog) Crestor (Rosuvastatin) – US: AstraZeneca files patent infringement suit against Watson in response to Para IV certification (Patent Docs) Efexor (Venlafaxine) – Australia: Federal Court blocks generic Efexor-XR: Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth Australia Pty Ltd (Patentology) (BAZPAT) (GenericsWeb) Fipronil – UK:… [read post]
2 Oct 2010, 8:43 am
Peter Rost e-mailDr. [read post]
22 Aug 2010, 10:16 pm
Click here, and it will take you to a page containing biographical and contact information and here to e-mail Will directly. [read post]
1 Apr 2010, 3:04 am
USPTO and Myriad Genetics (Docket Report) (Peter Zura's 271 Patent Blog) (Inventive Step) (Patently-O) (Holman's Biotech IP Blog) (Patent Docs) (Ladas & Parry) (Tech Transfer Blog) (ipwars.com) (Ars Technica) (BlawgIT) (IP Watch) (The Prior Art) US: Study suggests USPTO erred in broad claims of Myriad BRCA1 patent (Tech Transfer Blog) (Patent Docs) US: CAFC confirms written description requirement in Ariad v Lilly (IP Law Blog) (IP Osgoode) (IP Spotlight) (Ars Technica) US: Justifying… [read post]
9 Dec 2009, 3:59 pm
(Patent Docs) Loprox, Vanos (Ciclopirox) – US: Settlement announced in Loprox and Vanos patent dispute between Glenmark and Medicis (Patent Docs) Neupogen (Filgrastim) – US: E D Pennsylvania: Plaintiff seeks declaratory judgment of non-infringement and invalidity: Teva Pharmaceuticals USA, Inc. v. [read post]
13 Oct 2009, 9:59 pm
As part of the effort to encourage these companies to pool their patents, MSF has launched an e-mail writing campaign calling on Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline, Merck & Co, Pfizer, and Sequoia Pharmaceuticals to place specific HIV drug patents... [read post]
17 Sep 2009, 4:30 am
A couple of cases we've posted about recently started us thinking - a dangerous turn of events, we know. [read post]
17 Jul 2009, 2:29 pm
(E. [read post]
